Literature DB >> 27297965

Tetrabromobisphenol A and hexabromocyclododecane alter secretion of IL-1β from human immune cells.

Sharif Anisuzzaman1, Margaret M Whalen1.   

Abstract

Tetrabromobisphenol A (TBBPA) and hexabromocyclododecane (HBCD), flame retardant compounds used in epoxy resin circuit boards and upholstery, contaminate the environment and are found in human serum. Lymphocytes and monocytes are immune cells that, among other functions, secrete pro-inflammatory cytokines such as interleukin (IL)-1β, an important regulator of immune responsiveness and tissue growth and repair. Thus, if its levels are dysregulated, loss of proper immune function and increased invasiveness of tumors could ensue. This study examines whether exposures to varying concentrations (0.05-5.0 μM) of TBBPA and HBCD for 24 h, 48 h and 6 days interfere with the ability of immune cells to secrete IL-1β. The immune cell preparations examined were human natural killer (NK) cells, monocyte-depleted (MD) peripheral blood mononuclear cells (MD-PBMC) and PBMC. Both increased and decreased secretion of IL-1β from all three types of cell preparation were seen with TBBPA exposures and were dependent on concentration and length of exposure. TBBPA induced changes varied considerably from donor to donor. Exposure to HBCD from 0.5-5.0 μM caused increases in IL-1β secretion after all lengths of exposures in all cell preparations. The specific HBCD levels at which increases occurred varied among donors. Examinations of the signaling pathway(s) responsible for the elevated secretion of IL-1β after HBCD exposure were carried out in MD-PBMC cells. Results revealed that MAPK pathways (ERK1/2 and p38) appear to be the targets of HBCD that lead to increased IL-1β secretion from immune cells.

Entities:  

Keywords:  IL-1β; NK cells; PBMC; hexabromocyclododecane; tetrabromobisphenol A

Mesh:

Substances:

Year:  2015        PMID: 27297965      PMCID: PMC4910520          DOI: 10.3109/1547691X.2015.1111960

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  46 in total

1.  Cancer: an inflammatory link.

Authors:  Fran Balkwill; Lisa M Coussens
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

Review 2.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 3.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.

Authors:  Ron N Apte; Shahar Dotan; Moshe Elkabets; Malka R White; Eli Reich; Yaron Carmi; Xiaping Song; Tatyana Dvozkin; Yakov Krelin; Elena Voronov
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

Review 4.  Hexabromocyclododecanes (HBCDs) in the environment and humans: a review.

Authors:  Adrian Covaci; Andreas C Gerecke; Robin J Law; Stefan Voorspoels; Martin Kohler; Norbert V Heeb; Heather Leslie; Collin R Allchin; Jacob De Boer
Journal:  Environ Sci Technol       Date:  2006-06-15       Impact factor: 9.028

5.  Expression of interleukin-1beta in human breast carcinoma.

Authors:  L Jin; R Q Yuan; A Fuchs; Y Yao; A Joseph; R Schwall; S J Schnitt; A Guida; H M Hastings; J Andres; G Turkel; P J Polverini; I D Goldberg; E M Rosen
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

6.  Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.

Authors:  I A Meerts; J J van Zanden; E A Luijks; I van Leeuwen-Bol; G Marsh; E Jakobsson; A Bergman; A Brouwer
Journal:  Toxicol Sci       Date:  2000-07       Impact factor: 4.849

7.  Tetrabromobisphenol A has immunosuppressive effects on human natural killer cells.

Authors:  Esther Caroline Kibakaya; Krishna Stephen; Margaret M Whalen
Journal:  J Immunotoxicol       Date:  2009-12       Impact factor: 3.000

Review 8.  Why not treat human cancer with interleukin-1 blockade?

Authors:  Charles A Dinarello
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

9.  Hexabromocyclododecane decreases the lytic function and ATP levels of human natural killer cells.

Authors:  Natasha C Hinkson; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2009-11       Impact factor: 3.446

Review 10.  Brominated flame retardants: cause for concern?

Authors:  Linda S Birnbaum; Daniele F Staskal
Journal:  Environ Health Perspect       Date:  2004-01       Impact factor: 9.031

View more
  4 in total

1.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

2.  Flame retardants, hexabromocyclododecane (HCBD) and tetrabromobisphenol a (TBBPA), alter secretion of tumor necrosis factor alpha (TNFα) from human immune cells.

Authors:  Sharia Yasmin; Margaret Whalen
Journal:  Arch Toxicol       Date:  2018-01-22       Impact factor: 5.153

3.  Exposures to the environmental contaminants pentachlorophenol and dichlorodiphenyltrichloroethane increase production of the proinflammatory cytokine, interleukin-1β, in human immune cells.

Authors:  Tamara J Martin; JaQuel Maise; Sahra Gabure; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2019-03-25       Impact factor: 3.446

4.  Head-to-Head Study of Developmental Neurotoxicity and Resultant Phenotype in Rats: α-Hexabromocyclododecane versus Valproic Acid, a Recognized Model of Reference for Autism Spectrum Disorders.

Authors:  Chloé Morel; Armelle Christophe; Katy Maguin-Gaté; Justine Paoli; Jonathan David Turner; Henri Schroeder; Nathalie Grova
Journal:  Toxics       Date:  2022-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.